Physician profile

Robert A Statfeld

Anesthesiology · Port Charlotte, FL

NPI 1629069596

$919.50

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$381.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Chiesi USA, INC. $308.13 2021-2024 Cleviprex
Impulse Dynamics (USA) INC. $180.00 2024 Optimizer
Edwards Lifesciences Corporation $176.90 2021-2023 Sapien 3 Ultra Resilia
Lantheus Medical Imaging, INC. $141.16 2022
Cvrx, INC. $54.88 2020
Cardiva Medical, INC. $27.43 2023 Cardiva Vascade 6/7f Vcs
Getinge USA Sales, LLC $18.66 2022
Masimo Corporation $12.34 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert A Statfeld

$919.50

in general payments reported 2019-2025

Years
2020-2024
Top company
Chiesi USA, INC.

https://glasscript.com/doctor/1092863/robert-a-statfeld

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.